[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635974":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":26,"id":57,"slug":26,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":26,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University of Electronic Science and Technology of China","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Oxytocin","EXPERIMENTAL","A single dose of 24 international units of oxytocin will be administered with 3 puffs of treatment to each nostril.",[13],"Drug: Intranasal oxytocin",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","A single dose of 24 international units of placebo will be administered with 3 puffs of treatment to each nostril.",[19],"Drug: Intranasal placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Intranasal oxytocin","Each subject will be assigned to intranasally administered 24-IU of oxytocin.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Intranasal placebo","Each subject will be assigned to intranasally administered 24-IU of placebo.",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Shuxia Yao, Dr","CONTACT","18111297596","yaoshuxia@uestc.edu.cn",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Chengdu","Sichuan","611731","China","CN",{"type":46,"coordinates":47},"Point",[48,49],104.06667,30.66667,{"lat":49,"lon":48},[52],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Shuxia Yao","Associate Professor","100635974",false,"NCT07559656","Oxytocin's Effects on Real Time-fMRI Neurofeedback Training of Anterior Insula Activity","Effects of Intransal Oxytocin on Real-time fMRI Neurofeedback Training of Anterior Insula Activity Using an Interoceptive Strategy","Inclusion Criteria:\n\n* Healthy subjects without any past or present psychiatric or neurological disorders.\n\nExclusion Criteria:\n\n* History of brain injury medical or mental illness.\n* Contraindication to MRI scanning (e.g., metal implants, claustrophobia or other --conditions that make them inappropriate for MRI scanning).",true,"MALE","18 Years","30 Years",{"count":68,"type":69},80,"ESTIMATED","INTERVENTIONAL",[72],"NA","The primary aim of this study is to investigate whether intranasal oxytocin can modulate the real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback training effects by facilitating the use of an interoceptive strategy.",[75],"Healthy",[9,77,78,79],"Real-time neurofeedback","Anterior insula","Interoceptive strategy","2026-04-23",{"date":82,"type":83},"2026-04-30","ACTUAL",{"date":85,"type":69},"2026-04-26",{"date":87,"type":69},"2026-10-01",{"name":5,"class":6},1]